Lisa Earnhardt

Lisa Earnhardt

President and Chief Executive Officer

biography
Lisa joined Intersect ENT in 2008 as President and Chief Executive Officer and has led the company from early clinical stage. Previously, Lisa was President of Boston Scientific’s Cardiac Surgery division. Lisa has over two decades of experience in healthcare, primarily in leading global product launches and driving adoption of new medical technologies at both Boston Scientific and Guidant in a variety of sales and marketing leadership roles. Lisa began her career at APM/CSC Healthcare where she provided management consulting services to healthcare provider organizations. She serves on the boards of Intersect ENT and Nevro Corporation (NYSE: NVRO). Lisa is a member of the board of directors of Advanced Medical Technology Association (AdvaMed), the Kellogg Global Advisory board, and Young Presidents’ Organization. Lisa holds a B.S. in Industrial Engineering from Stanford University and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.
Jeryl (Jeri) Hilleman

Jeryl (Jeri) Hilleman

Chief Financial Officer

biography
Jeri has served as Chief Financial Officer for over 20 years. She has taken five life science companies public and served many years as a public company CFO. Prior to joining Intersect ENT, Jeri was CFO of Ocera Therapeutics (Nasdaq: OCRX), and CFO of Amyris, Inc. (Nasdaq: AMRS), a multi-national, public, renewable products company based in California and Brazil. She was also CFO of Symyx Technologies, (since acquired), as well as Geron and Cytel Corporation (acquired). Jeri serves on the board of directors and chair of the audit committee of Xenoport (Nasdaq: XNPT), a biopharmaceutical company focused on the treatment of neurological disorders, and is a member of the Board of Trustees of GeoHazards International. She holds an A.B. from Brown University and an M.B.A. from the Wharton Graduate School of Business. She is a member of the 1999 class of Henry Crown Fellows and the Aspen Global Leadership Network at the Aspen Institute.
Rich Kaufman

Rich Kaufman

Chief Operating Officer

biography
As one of Intersect ENT’s first employees, Rich has contributed greatly to the design of the Company’s commercial and in-development products. Prior to joining Intersect ENT, Rich was the VP and GM of Abbott Bioabsorbable Vascular Solutions where he led the team to the first ever successful implantation of and clinical trial for a fully bioabsorbable drug eluting coronary stent. Previously, Rich held a variety of R&D and Manufacturing management roles within Guidant’s Vascular Intervention division, leading many successful medical device products from concept to commercialization. Prior to joining Guidant, Mr. Kaufman worked at McGhan Medical developing products for the plastic surgery field and at IMPRA developing products for orthopedics and vascular grafts. Mr. Kaufman holds a B.S. in Biomedical Engineering from Arizona State University.
David Lehman

David Lehman

General Counsel

biography
David serves as in-house general counsel. He was previously with Thoratec, a global leader in medical technology to address advanced stage heart failure, as Vice President, General Counsel and Secretary (since May 2003) and Senior Vice President (since 2007) prior to Thoratec’s sale to St. Jude Medical in 2015. Prior to that, he was Vice President and General Counsel at Brigade Corporation, a business process outsourcing company, and previously held positions in the legal departments of Bio-Rad Laboratories, Inc., a life science research and clinical diagnostics company, and Mitsubishi International Corporation, a Japanese trading company, in their New York and Tokyo offices. He began his career as an associate attorney at the law firm of Hall, Dickler, Kent, Friedman & Wood in New York. David holds a B.A. in political science from The University of California, San Diego and a J.D. from Cornell University Law School.
David Lehman

Gwen Carscadden

Chief People Officer

biography
Gwen joined the team in June of 2016, and serves as Intersect ENT’s Chief People Officer. She has over 25 years of experience in Human Resources in both high technology and life sciences sectors. Prior to joining Intersect ENT, Gwen served as Senior Vice President of Human Resources at CardioDx, Inc. a privately held Medical Diagnostics company. Before that, Gwen was Vice President of Human Resources for Facet Biotech, which was acquired by Abbott Laboratories. She served as an Executive Director of Human Resources for PDL Biopharma, and she began her career in the technology sector, working for Amdahl Corporation and Fujitsu Computer Systems. Gwen holds an M.A. in Organizational Communication from San Jose State University and a B.A. in Behavioral Sciences also from San Jose State.
Robert Binney

Robert Binney

Vice President,  Global Sales

biography
Rob has extensive sales leadership, sales training and sales execution experience in the medical device and pharmaceutical industries. Prior to joining Intersect ENT, Rob was Director of Sales for AccessClosure, Inc., a privately-held medical device company where Rob successfully built and led a team of 60 sales professionals, playing a significant role in the organization’s growth from no sales in June 2007 to over $70 million in 2010. Previously, Rob was a top performing sales professional and trainer at Boston Scientific in the peripheral and vascular surgery markets. He began his medical sales career with Aventis Pharmaceuticals and holds a B.A. in Communications from the University of North Carolina at Chapel Hill.
Betsy Gross

Betsy Gross

Vice President, Healthcare Economics & Reimbursement

biography
Betsy has over 25 years of experience supporting technology commercialization across various specialties in the biotech and medical device industries. Prior to Intersect ENT, Betsy was Director of Health Economics and Reimbursement at Acclarent, a Johnson & Johnson company, where she led payor coverage policy initiatives to expand patient access to Balloon Sinuplasty™. Previously, she was responsible for the strategic reimbursement direction of Edwards Lifesciences’ Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular Business units for products from development through commercialization in both US and OUS markets. She worked in similar capacities for Cyberonics and Medtronic’s Neurological business unit. Betsy is a Registered Nurse with a B.S. in Nursing from Villanova University and she is a Certified Professional Coder with additional certifications in hospital and ENT coding.
James Stambaugh

James Stambaugh

Vice President, Clinical Affairs

biography
As our second employee, James has led Intersect ENT’s clinical strategy and programs from inception as well as had far-reaching impact on ensuring patients and physicians have access to our technologies. James has over 20 years’ experience in medical device and pharmaceutical development including regulatory affairs, design and management of human clinical trials, conduct of in-vivo and in-vitro pre-clinical experiments, experience with design controls, design validation, and risk analysis. Prior to joining Intersect ENT, James was Director of Clinical Operations at Guidant’s Vascular Intervention division, responsible for conducting clinical studies for coronary embolic protection, stents, and drug-eluting stents. During his tenure at Guidant, James held various positions within the pre-clinical, clinical and regulatory environment. James started his career as an analytical chemist at an ophthalmic pharmaceutical company, InSite Vision, and later transitioned into clinical research. He holds a B.S. in Chemistry from the University of California at Davis.
Susan Stimson

Susan Stimson

General Manager, RESOLVE

biography
With 20 years of experience in the healthcare arena, Susan is recognized as a respected leader and expert in commercialization of new medical technologies. Joining Intersect ENT as the 10th employee in 2007, Susan has played an instrumental role in building the company from R&D stage to a high growth commercial business leading the areas of Marketing, Customer Service and International Expansion. Susan has impacted top priority products from the aspects of marketing, sales, R&D, clinical research, and manufacturing at both start-up and large companies including many years at Guidant. Ms. Stimson holds a B.S. in Biomedical Engineering from Marquette University.
Amy Wolbeck

Amy Wolbeck

Vice President, Regulatory Affairs

biography
Amy has an extensive background in regulatory and quality in the medical device industry. Prior to joining Intersect ENT, she held Director positions at Medtronic’s Cardiovascular Division as well as Sonoma Orthopedic Products. Before that, she worked for several years as a regulatory and quality consultant providing expertise to the medical device, biotech and pharmaceutical industries. Amy has extensive experience with the design and implementation of Quality Systems and for bringing Class I/II/III Medical Devices to market, including Class III combination product implants. She holds a B.S. in Mechanical Engineering from the University of Massachusetts at Amherst.